Pain medicine

High-risk Opioid Prescribing Associated with Postoperative New Persistent Opioid Use in Adolescents and Young Adults

Ann SurgPublished Retrospective cohort study

Main finding · Persistent opioid useResult — go to the resultAdjusted odds ratio 1.235 CI 1.12,1.36

Authors' conclusion

High-risk opioid prescribing practices, particularly receiving prescriptions from multiple prescribers across specialties, were associated with a significant increase in adolescent and young adult patients' risk of persistent opioid use.

Study context

Population
Opioid-naïve patients aged 13 to 21 who underwent 1 of 13 procedures (2008–2016) and filled a perioperative opioid prescription
Exposure
High-risk opioid prescribing vs no high-risk prescribing
Outcome
Persistent opioid use (≥ 1 opioid prescription fill 91 to 180 days after surgery)
Follow-up
91 to 180 days after surgery
Methodological detailscommercial insurance claims database
  • Commercial insurance claims database

Main finding

Persistent opioid use

Adjusted odds ratio

1.235

CI 1.12,1.36

High-risk prescribing vs No high-risk prescribing
aOR 1.235 (CI 1.12,1.36)

As reported in the abstract

Observational data: associations, not effects.

Further findings

Persistent opioid use, multiple opioid prescribers

aOR (CI)
Multiple prescribers1.288 (1.16,1.44)

Trend in high-risk opioid prescribing over study period

Co-prescribed benzodiazepines increased (largest increase)
24.1%-33.4%
High-risk prescribing increased from 34.9% to 43.5%

Prescriptions from nonsurgical prescribers among persistent users beyond the postoperative period

Majority of opioid prescriptions from nonsurgical prescribers
79.6%

Original publication

High-risk Opioid Prescribing Associated with Postoperative New Persistent Opioid Use in Adolescents and Young Adults. Ann Surg. Published 27 August 2021. doi:10.1097/sla.0000000000005193

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.